Atlas Trials

PK//PD/Tolerability Study of DA-1229(Evogliptin) in Renal Impaired Patients

Clinical trial NCT02214693 · COMPLETED

Trial details

NCT number
NCT02214693
Sponsor
Dong-A ST Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Impairment
Start date
2014-07-01
Primary completion
2015-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.